#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Non-small cell lung cancer Hereditary hypophosphataemic rickets White matter lesion Chronic lymphocytic leukaemia Leukoencephalopathy Angiosarcoma recurrent Soft tissue necrosis Angiosarcoma non-metastatic Fallopian tube cancer Peritoneal mesothelioma malignant HER2 mutant non-small cell lung cancer Crigler-Najjar syndrome Epstein-Barr virus infection Ataxia telangiectasia Meningococcal immunisation More trials…

    Learn about Rare Diseases

    Osteosarcoma – Basic Information Familial haemophagocytic lymphohistiocytosis – Treatment Noonan syndrome – Diagnostics Leiomyosarcoma metastatic – Treatment Methylmalonic acidaemia – Life with Disease Gastrointestinal stromal tumour – Treatment Von Willebrand’s disease – Treatment Prolymphocytic leukaemia – Diagnostics MELAS syndrome – Treatment Mastocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Salmeterol Xinafoate Bgb-15025 Citrate Magnesium Bupivacaine Hydrochloride Ion440 Trastuzumab Felzartamab Oxytocin Padeliporfin YOHIMBINE HYDROCHLORIDE Cilastatin BMS-986470 Abiraterone Naltrexone Hydrochloride Estradiol Valerate Everolimus Resiniferatoxin Autologous Pancreatic Islets Cpft Trifluoroacetate Garadacimab More therapies…

    Learn about Your Condition

    Breast cancer stage I Infection External cephalic version Mucosal inflammation Cold type haemolytic anaemia Giardiasis Malignant melanoma of eyelid Leiomyosarcoma Basal cell naevus syndrome Primary hypogonadism Juvenile psoriatic arthritis Peripheral ischaemia Epidermolysis bullosa Enteritis Renal cell carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Quality of Life and Brain Function in Patients with Diffuse Low-Grade Gliomas Treated with Temozolomide

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Temozolomide
    France

  • Comparison of Surgical Treatment versus Cabergoline in Patients with Newly Diagnosed Microprolactinomas

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Prolactin-producing pituitary tumour
    Investigated Drugs:
    • Cabergoline
    Italy

  • Study on the Safety and Tumor-Fighting Effects of OMO-103 for Patients with Advanced Osteosarcoma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Osteosarcoma metastatic
    Investigated Drugs:
    • Omo-103
    Spain

  • Study of tezepelumab in patients with progressive pulmonary fibrosis and increased eosinophil levels in blood

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    • Interstitial lung disease
    Investigated Drugs:
    • Tezepelumab
    Germany

  • Detecting Heart Inflammation in Cardiac Sarcoidosis Patients Using 68Ga-NOTA-Anti-MMR-VHH2 PET-CT Imaging

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac sarcoidosis
    Investigated Drugs:
    • Nanobody Against Macrophage Mannose Receptor, Conjugated With 1,4,7-Triazacyclononane-N,N’,N”-Triacetic Acid, Labelled With Gallium Ga-68
    Belgium

  • Study on Improving Sexual Function in Men and Women After Rectal Cancer Treatment Using Tadalafil

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Tadalafil
    Sweden
Previous Page
1 … 856 857 858 859 860 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!